rep profile
rep profile
Chris Tremains
Company
Novartis Pharmaceuticals
Title
Territory representative
Current home
Columbus, OH
Territory:Â Columbus and Southern Ohio.
Customers:Â Primary care physicians, rheumatologists, OB/GYNs, endocrinologists and internists.
Awards:Â District sales award.
Selling techniques:Â "I tailor my presentation to fit the needs of each customer. Because a physician is giving me his or her valuable time, I feel it is important to give them valuable, concise information. I get to the point quickly. Also, I am always redoing my sales binder. I try to keep it fresh. Novartis provides motivational tapes for its employees, so I listen to these while I am in my car. I also read many different books on selling; one particular book I really like is 'Hardball Selling,' by Robert Schuck."
Sales philosophy:Â "I provide professional information about my products with all the staff in the doctor's office. I think it is important that my customers see me as a professional and know that I provide valuable information for their patients. Also, I don't run down the competition. I build a strong partnership with the physicians based on trust, ethics and credibility."
Teamwork and motivation:Â "I find teamwork to be very motivating. Working together as a team requires everyone to keep up their end of project. My co-workers and I provide daily reinforcement for each other."
Volunteer work:Â "I volunteer for Refugee Services. I teach English as a second language to immigrants, as well as Government and American history. This prepares them for their citizenship examination. It's neat to see our country through their eyes."
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.